Compare CNXN & PBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CNXN | PBH |
|---|---|---|
| Founded | 1982 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.4B |
| IPO Year | 1997 | 2004 |
| Metric | CNXN | PBH |
|---|---|---|
| Price | $79.82 | $52.75 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $75.33 |
| AVG Volume (30 Days) | 123.7K | ★ 510.5K |
| Earning Date | 04-29-2026 | 05-08-2026 |
| Dividend Yield | ★ 1.26% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.99 | 0.61 |
| Revenue | N/A | ★ $975,777,000.00 |
| Revenue This Year | $6.24 | N/A |
| Revenue Next Year | $4.39 | $4.31 |
| P/E Ratio | ★ $40.14 | $84.89 |
| Revenue Growth | N/A | ★ 36.77 |
| 52 Week Low | $54.97 | $42.62 |
| 52 Week High | $88.31 | $71.07 |
| Indicator | CNXN | PBH |
|---|---|---|
| Relative Strength Index (RSI) | 49.92 | 55.35 |
| Support Level | $76.20 | $50.49 |
| Resistance Level | $88.31 | $53.11 |
| Average True Range (ATR) | 2.05 | 1.35 |
| MACD | -0.17 | -0.02 |
| Stochastic Oscillator | 58.67 | 77.47 |
PC Connection Inc is a provider of information technology solutions. It provides products such as computer systems, software and peripheral equipment, networking communications, and other products and accessories that company purchase from manufacturers and distributors. The company also offers services involving design, configuration, and implementation of IT solutions. It conducts business operations through three business segments namely Connection Business Solutions, Connection Enterprise Solutions, and Connection Public Sector Solutions. The company generates maximum revenue Connection Enterprise Solutions segment.
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.